Origin Therapeutics Holdings (XCNQ:ORIG) ROCE % : -11.82% (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Origin Therapeutics Holdings's annualized ROCE % for the quarter that ended in Jun. 2023 was -11.82%.

Origin Therapeutics Holdings ROCE % Historical Data

The historical data trend for Origin Therapeutics Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings ROCE % Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

ROCE %

-16.53

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
ROCE %	Get a 7-Day Free Trial				-14.38	-21.53	-9.77	-20.18	-11.82

Origin Therapeutics Holdings ROCE % Calculation

Origin Therapeutics Holdings's annualized ROCE % for the fiscal year that ended in Sep. 2022 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Sep. 2022 )		(A: Sep. 2021 )		(A: Sep. 2022 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Sep. 2022 )		(A: Sep. 2021 )		(A: Sep. 2022 )
	=	-1.017	/	( ( (7.059 - 0.18)	+	(5.588 - 0.159) )	/ 2 )
	=	-1.017	/	( (6.879	+	5.429)	/ 2 )
	=	-1.017	/	6.154
	=	-16.53 %

Origin Therapeutics Holdings's ROCE % of for the quarter that ended in Jun. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2023 )		(Q: Mar. 2023 )		(Q: Jun. 2023 )
	=	-0.368	/	( ( (3.369 - 0.224)	+	(3.191 - 0.11) )	/ 2 )
	=	-0.368	/	( ( 3.145	+	3.081 )	/ 2 )
	=	-0.368	/	3.113
	=	-11.82 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2023) EBIT data.

Origin Therapeutics Holdings (XCNQ:ORIG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Origin Therapeutics Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.